- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Merrimack Pharmaceuticals is a biotechnology business based in the US. Merrimack Pharmaceuticals shares (MACK) are listed on the NASDAQ and all prices are listed in US Dollars.
What's in this guide?
- MACK shares summary
- Compare share dealing platforms
- Is MACK stock a buy or sell?
- Stock performance over time
- Can I short MACK shares?
- Are MACK shares over-valued?
- Merrimack Pharmaceuticals's financials
- How volatile are MACK shares?
- Does Merrimack Pharmaceuticals pay a dividend?
- Have MACK shares ever split?
- Other common questions
Our top picks for where to buy Merrimack Pharmaceuticals stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
How to buy Merrimack Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – MACK. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Merrimack Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Merrimack Pharmaceuticals stock price (NASDAQ: MACK)
Use our graph to track the performance of MACK stocks over time.Merrimack Pharmaceuticals shares at a glance
52-week range | $12.94 - $15.89 |
---|---|
50-day moving average | $14.84 |
200-day moving average | $13.48 |
Wall St. target price | $4.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-0.09 |
Is it a good time to buy Merrimack Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Merrimack Pharmaceuticals stock undervalued or overvalued?
Valuing Merrimack Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Merrimack Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Merrimack Pharmaceuticals's PEG ratio
Merrimack Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Merrimack Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Merrimack Pharmaceuticals financials
Gross profit TTM | $-9,100,000 |
---|---|
Return on assets TTM | -1.07% |
Return on equity TTM | -1.12% |
Profit margin | 0% |
Book value | $15.25 |
Market Capitalization | $223.7 million |
TTM: trailing 12 months
Merrimack Pharmaceuticals share dividends
We're not expecting Merrimack Pharmaceuticals to pay a dividend over the next 12 months.
Have Merrimack Pharmaceuticals's shares ever split?
Merrimack Pharmaceuticals's shares were split on a 1:10 basis on 5 September 2017 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Merrimack Pharmaceuticals shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Merrimack Pharmaceuticals shares which in turn could have impacted Merrimack Pharmaceuticals's share price.
Merrimack Pharmaceuticals share price volatility
Over the last 12 months, Merrimack Pharmaceuticals's shares have ranged in value from as little as $12.94 up to $15.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Merrimack Pharmaceuticals's is 1.416. This would suggest that Merrimack Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Merrimack Pharmaceuticals overview
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. .
Frequently asked questions
What percentage of Merrimack Pharmaceuticals is owned by insiders or institutions?Currently 1.191% of Merrimack Pharmaceuticals shares are held by insiders and 62.978% by institutions. When does the fiscal year end for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals's fiscal year ends in December. Where is Merrimack Pharmaceuticals based?
Merrimack Pharmaceuticals's address is: One Broadway, Cambridge, MA, United States, 02142 What is Merrimack Pharmaceuticals's ISIN number?
Merrimack Pharmaceuticals's international securities identification number is: US5903282094 What is Merrimack Pharmaceuticals's CUSIP number?
Merrimack Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 590328209
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to gift stock
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
Acorns review 2024
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.
Ask a question